2021. Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s9. DOI:https://doi.org/10.25251/skin.5.supp.9.